J&J raises revenue forecast, estimates $2.5 bln in COVID-19 vaccine sales
Johnson & Johnson on Wednesday forecast $2.5 billion in sales of its one-shot COVID-19 vaccine this year based on the current price of $5 per dose and said that could rise to $8 ...